NCT00872404 2016-04-20
A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 2 Terminated
Clinical Trials
14 trialsNCT00678626 2015-05-04
Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer
Pfizer
Phase 2 Withdrawn
NCT00635245 2015-03-11
CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery
Pfizer
Phase 1 Withdrawn
NCT00907504 2014-06-17
ADVIGO1017
Pfizer
Phase 3 Withdrawn
NCT00729833 2014-06-09
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT00596830 2014-01-13
Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
Pfizer
Phase 3 Terminated
NCT00976508 2013-12-13
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT00927966 2013-11-14
RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms
Dana-Farber Cancer Institute
Phase 1 Completed
NCT00147537 2013-10-30
Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
Pfizer
Phase 1/2 Completed
NCT00673049 2013-07-24
NSCLC
Pfizer
Phase 3 Terminated
NCT00603538 2013-04-11
Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer
Pfizer
Phase 1 Completed
NCT00560573 2013-03-21
Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer
Pfizer
Phase 1 Completed
NCT01536145 2013-03-15
CP-751,871 Treatment For Patients With Multiple Myeloma
Pfizer
Phase 1 Completed
NCT00977561 2013-02-25
A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer
Pfizer
Phase 2 Terminated